Diversified Healthcare Trust
Price Action
Technical Summary
STAGE 2 UPTRENDDiversified Healthcare Trust is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 91), indicating clear outperformance against the broad market. Earnings growth of 75% provides fundamental context to the price action. Investors should exercise caution due to high volatility (53% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.30 | +7.36% | ABOVE |
| 50 SMA | $5.72 | +18.27% | ABOVE |
| 100 SMA | $5.10 | +32.68% | ABOVE |
| 150 SMA | $4.70 | +43.73% | ABOVE |
| 200 SMA | $4.39 | +53.98% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is DHC in an uptrend right now?
DHC has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, DHC is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is DHC overbought or oversold?
DHC's RSI (14) is 68. The stock is in neutral territory, neither overbought nor oversold.
Is DHC outperforming the market?
DHC has a Relative Strength (RS) Rating of 91 out of 99. Yes, DHC is a market leader, outperforming 91% of all stocks over the past 12 months.
Where is DHC in its 52-week range?
DHC is trading at $6.76, which is 99% of its 52-week high ($6.85) and 98% above its 52-week low ($2.00).
How volatile is DHC?
DHC has a Beta of 0.75 and 52-week volatility of 53%. It's less volatile than the S&P 500 - generally more stable.